Publications - 'C'
Publications 926 - 950 de 2875
| Titre | DOI |
|---|---|
|
Circular dichroism of magnetically induced transitions for D-2 lines of alkali atoms A. Tonoyan; A. Sargsyan; E. Klinger; G. Hakhumyan; C. Leroy; M. Auzinsh; A. Papoyan; D. Sarkisyan 2018 |
10.1209/0295-5075/121/53001 |
|
Circular Laser/Camera-Based Attitude and Altitude Estimation: Minimal and Robust Solutions R. Boutteau; P. Sturm; P. Vasseur; C. Demonceaux 2018 |
10.1007/s10851-017-0764-y |
|
Circulating Apelin is increased in patients with type 1 or type 2 diabetes and is associated with better glycaemic control M. Habchi; L. Duvillard; V. Cottet; M.C. Brindisi; B. Bouillet; M. Beacco; E. Crevisy; P. Buffier; S. Baillot-Rudoni; B. Verges; J.M. Petit 2014 |
10.1111/cen.12404 |
|
Circulating cell-free DNA in patients with alveolar echinococcosis A. Baraquin; E. Hervouet; C. Richou; P. Flori; P. Peixoto; A. Azizi; E. Delabrousse; O. Blagosklonov; G. Umhang; S. Bresson-Hadni; B. Valot; F. Grenouillet; S. Felix; B. Heyd; G. Mantion; V. Di Martino; D. Montange; C. Vanlemmens; D.Angele Vuitton; D. Weil-Verhoeven; P. Chavanet; F. Dalle; S. Gohier; A. Minello; L. Piroth; J. Dumortier; J.Y. Mabrut; M. Wallon; E. Frentiu; M. Machouart; J. Watelet; C. Chemla; T. Feron; A. Heurge-Berlot; D. Sommacale; G. Thiefin; A. Abou-Bacar; J. Brunet; E. Candolfi; Y. Hansmann; N. Lefebvre; E.V.Study Grp 2018 |
10.1016/j.molbiopara.2018.04.004 |
|
Circulating current reduction-based hybrid controller of an electrical drive system fed by two parallel inverters E. Zaidi; K. Marouani; H. Bouadi; K. Nounou; M. Becherif 2021 |
10.1007/s00202-021-01284-8 |
|
Circulating ESR1 mutation detection rate and early decrease under first line aromatase inhibitor and palbociclib in the PADA-1 trial (UCBG-GINECO) F.C. Bidard; B. Pistilli; F. Dalenc; D.La Motte Rouge; R. Sabatier; J.S. Frenel; S. Ladoire; C. Dubot; J.M. Ferrero; C. Levy; A. Lortholary; L. Stefani; M.A. Mouret-Reynier; A.C. Hardy; J.P. Jacquin; J. Grenier; C. Chakiba; L. Teixeira; P. Soulie; S. Everhard; J. Lemonnier; E. Jeannot; I. Bieche; F. Berger; J.Y. Pierga; T. Bachelot; S. Delaloge 2019 |
10.1158/1538-7445.SABCS18-PD2-06 |
|
Circulating Interferon-alpha Measured With a Highly Sensitive Assay as a Biomarker for Juvenile Inflammatory Myositis Activity: Comment on the Article by Mathian et al I. Melki; H. Devilliers; C. Gitiaux; V. Bondet; A. Belot; C. Bodemer; P. Quartier; Y.J. Crow; D. Duffy; M.P. Rodero; B.Bader Meunier 2020 |
10.1002/art.41096 |
|
Circulating levels of 3-hydroxymyristate, a direct quantification of endotoxaemia in noninfected cirrhotic patients D. Weil; J.P.Pais de Barros; G. Mourey; C. Laheurte; B. Cypriani; N. Badet; E. Delabrousse; E. Grandclement; V. Di Martino; P. Saas; L. Lagrost; T. Thevenot 2019 |
10.1111/liv.13916 |
|
Circulating microRNAs and outcome in patients with acute heart failure E. Goretti; M.F. Seronde; M. Vausort; E. Gayat; T. Thum; A. Cohen-Solal; D.R. Wagner; A. Mebazaa; Y. Devaux 2014 |
10.1093/cvr/cvu082.14 |
|
Circulating microRNAs and Outcome in Patients with Acute Heart Failure M.F. Seronde; M. Vausort; E. Gayat; E. Goretti; L.L. Ng; I.B. Squire; N. Vodovar; M. Sadoune; J.L. Samuel; T. Thum; A.Cohen Solal; S. Laribi; P. Plaisance; D.R. Wagner; A. Mebazaa; Y. Devaux; G.R.E.A.T. Network 2015 |
10.1371/journal.pone.0142237 |
|
Circulating microRNAs and outcome in patients with acute heart failure E. Goretti; M.F. Seronde; M. Vausort; E. Gayat; T. Thum; C. Solal; D.R. Wagner; A. Mebazaa; Y. Devaux 2014 |
|
|
Circulating microRNAs and outcome in patients with acute heart failure E. Goretti; M.F. Seronde; M. Vausort; E. Gayat; T. Thum; A. Cohen-Solal; D.R. Wagner; A. Mebazaa; Y. Devaux 2014 |
|
|
Circulating microRNAs and outcome in patients with acute heart failure E. Goretti; M.F. Seronde; M. Vausort; E. Gayat; T. Thum; C. Solal; D.R. Wagner; A. Mebazaa; Y. Devaux 2014 |
|
|
Circulating miR-126 as a Potential Non-invasive Biomarker for Intracra-nial Aneurysmal Rupture: A Pilot Study J. Wu; I. Gareev; O. Beylerli; A. Mukhamedzyanov; V. Pavlov; D. Khasanov; G. Khasanova 2021 |
10.2174/1567202619666211217142116 |
|
Circulating mir-21 and mir-146a are associated with increased cytokines and CD36 in Algerian obese male participants H. Benbaibeche; A. Hichami; B. Oudjit; E.Mahdi Haffaf; G. Kacimi; E.Ahmed Koceir; N.Akhtar Khan Submitted |
10.1080/13813455.2020.1775655, Early Access Date = {JUN 2020 |
|
Circulating NKp46(+) Natural Killer cells have a potential regulatory property and predict distinct survival in Non-Small Cell Lung Cancer E. Picard; Y. Godet; C. Laheurte; M. Dosset; J. Galaine; L. Beziaud; R. Loyon; L. Boullerot; E.Lauret Mar Joseph; L. Spehner; M. Jacquin; G. Eberst; B. Gaugler; F. Le Pimpec-Barthes; E. Fabre; V. Westeel; A. Caignard; C. Borg; O. Adotevi 2019 |
10.1080/2162402X.2018.1527498 |
|
Circulating PCSK9 levels are not associated with the severity of hepatic steatosis and NASH in a high-risk population M. Wargny; P.H. Ducluzeau; J.M. Petit; C. Le May; S. Smati; L. Arnaud; M. Pichelin; B. Bouillet; A. Lannes; O. Blanchet; P. Lefebvre; S. Francque; L. Van Gaal; B. Staels; B. Verges; J. Boursier; B. Cariou 2018 |
10.1016/j.atherosclerosis.2018.09.008 |
|
Circulating PD-L1-exosomes to monitor tumor response in melanoma patients C. Nardin; M. Cordonnier; G. Chanteloup; V. Derangere; M. Algros; L. Arnould; C. Garrido; F. Aubin; J. Gobbo 2019 |
10.1016/j.jid.2019.07.571 |
|
Circulating PD-L1-exosomes to monitor tumor response in melanoma patients. C. Nardin; M. Cordonnier; G. Chanteloup; V. Derangere; M.Paule Algros; G. Marcion; L. Arnould; C. Garrido; F. Aubin; J. Gobbo 2019 |
10.1200/JCO.2019.37.15_suppl.9517 |
|
Circulating tumor cells (CTC) and endothelial cells (CEC) changes in HER2 negative metastatic breast cancer (MBC) patients treated with first line weekly paclitaxel and bevacizumab: Preliminary results of a prospective cohort from the French Breast Cancer J.Y. Pierga; I. Vaucher; M. Gutierrez; O. Tredan; S. Guiu; G. Romieu; A. Goncalves; M. Debled; C. Levy; J.M. Ferrero; C. Jouannaud; E. Luporsi; M.A. Mouret-Reynier; F. Dalenc; B. Asselain; J. Lemonnier; F.C. Bidard 2015 |
|
|
Circulating tumor cells (CTC) and endothelial cells (CEC) prognostic value in HER2 negative metastatic breast cancer patients treated with first line weekly paclitaxel and bevacizumab: First results of a prospective cohort from the French Breast Cancer In J.Y. Pierga; O. Tredant; M. Chevrier; C. Dubot; V. Lorgis; G. Romieu; A. Goncalves; M. Debled; C. Levy; J.M. Ferrero; C. Jouannaud; E. Luporsi; M.A. Mouret-Reynier; F. Dalenc; F. Berger; J. Lemonnier; C. Proudhon; F.C. Bidard 2017 |
10.1158/1538-7445.SABCS16-P1-01-02 |
|
Circulating Tumor Cells and Circulating Tumor DNA Detection in Potentially Resectable Metastatic Colorectal Cancer: A Prospective Ancillary Study to the Unicancer Prodige-14 Trial F.C. Bidard; N. Kiavue; M. Ychou; L. Cabel; M.H. Stern; J. Madic; A. Saliou; A. Rampanou; C. Decraene; O. Bouche; M. Rivoire; F. Ghiringhelli; E. Francois; R. Guimbaud; L. Mineur; F. Khemissa-Akouz; T. Mazard; D. Moussata; C. Proudhon; J.Y. Pierga; T. Stanbury; S. Thezenas; P. Mariani 2019 |
10.3390/cells8060516 |
|
Circulating tumor cells as a tool to guide first line therapy in metastatic breast cancer: subgroup analyses of the STIC CTC Phase III utility trial F.C. Bidard; W. Jacot; S. Dureau; E. Brain; T. Bachelot; H. Bourgeois; A. Goncalves; S. Ladoire; H. Naman; F. Dalenc; J. Gligorov; M. Espie; C. Levy; J.M. Ferrero; D. Loirat; P. Cottu; V. Dieras; M.E. Legrier; F. Berger; C. Alix-Panabieres; J.Y. Pierga 2019 |
10.1158/1538-7445.AM2019-CT140 |
|
Circulating tumor cells as prognostic marker in ovarian carcinoma: Results from the ANTHALYA study D.La Motte Rouge; P. Cottu; P. Pautier; M. Provansal; A. Floquet; F. Selle; M. Fabbro; E. Kalbacher; P. Follana; A.F. Lesoin; J. Medioni; J. Dupin; R.M. Ferri; F.C. Bidard; C. Dubot; R. Rouzier; J. Lobbedez 2017 |
|
|
Circulating tumor cells kinetics in ovarian carcinoma: correlation with baseline characteristics and CA-125 levels in the randomized ANTHALYA trial evaluating bevacizumab in the neoadjuvant setting P. Cottu; D.La Motte Rouge; P. Pautier; M. Provansal; A. Floquet; F. Selle; M.A. Mouret-Reynier; M. Fabbro; E. Kalbacher; C. Piprot; P. Follana; A. Lesoin; J. Medioni; V. Menguy; Y. Ghazi; F.C. Bidard; C. Dubot; F. Joly 2015 |
10.1016/S0959-8049(16)31538-6 |